Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Open in API
Filings indexed 1,216 across all filing types
Latest filing 2023-07-08 Director's Dealing
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2023-07-08 English
Regulatory Filings 2023
Regulatory Filings
2023-07-05 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 13, 2023, by Pacira BioSciences, Inc. It reports on the Annual Meeting of Stockholders held on the same date, including voting results on various proposals such as election of directors, ratification of auditors, executive compensation, and approval of a stock incentive plan. The key content is the submission of matters to a vote of security holders and the official voting results. There is no detailed financial data or comprehensive report content, but rather a summary of voting outcomes and related corporate governance matters. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5334 characters, which is sufficient to include detailed voting results rather than a mere announcement of a report publication. Therefore, the correct classification is DVA with high confidence.
2023-06-20 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-16 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-16 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.